STORM Therapeutics Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers
Phase 1
Recruiting
- Conditions
- Metastatic Non-small Cell Lung CancerMetastatic MelanomaMetastatic Endometrial CancerMetastatic Head-and-neck Squamous-cell CarcinomaSolid Tumor
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- STORM Therapeutics LTD
- Target Recruit Count
- 188
- Registration Number
- NCT06975293
- Locations
- 🇺🇸
Northwell Health Cancer Institute, Lake Success, New York, United States
🇺🇸The START Center, San Antonio, Texas, United States
🇺🇸NEXT Oncology, Fairfax, Virginia, United States
Oral Administration of STC-15 in Subjects with Advanced Malignancies
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- STORM Therapeutics LTD
- Target Recruit Count
- 42
- Registration Number
- NCT05584111
- Locations
- 🇺🇸
Honor Health, Scottsdale, Arizona, United States
🇺🇸The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸South Texas Accelerated Research Therapeutics, San Antonio, Texas, United States
News
No news found